4//SEC Filing
Gall Matthew 4
Accession 0000950170-23-068901
CIK 0001808865other
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 8:21 PM ET
Size
4.8 KB
Accession
0000950170-23-068901
Insider Transaction Report
Form 4
Gall Matthew
Chief Financial Officer
Transactions
- Award
Common Stock
2023-12-05+41,000→ 60,429 total
Footnotes (1)
- [F1]The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. All of the shares of common stock underlying such RSUs will vest on December 5, 2025, subject to the Reporting Person's continued service to the Issuer.
Documents
Issuer
iTeos Therapeutics, Inc.
CIK 0001808865
Entity typeother
Related Parties
1- filerCIK 0001816194
Filing Metadata
- Form type
- 4
- Filed
- Dec 6, 7:00 PM ET
- Accepted
- Dec 7, 8:21 PM ET
- Size
- 4.8 KB